Clinical trial
Head and Neck Cancer Omics-integrated Precision mEdicine (HOPE)
NCT07190573 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Head and Neck Cancer Omics-integrated Precision mEdicine (HOPE)
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 25, 2025
- Completion date
- January 31, 2030
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer